Đang chuẩn bị liên kết để tải về tài liệu:
Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Vascular mimicry (VM) was associated with the prognosis of cancers. The aim of the study was to explore the association between VM and anticancer therapy response in patients with lung adenocarcinoma. |

TÀI LIỆU LIÊN QUAN

Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: Role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling

Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition

Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/ Ln-5γ2 signaling pathway

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix

Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: A systematic review

Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines

Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status

The role of vascular mimicry as a biomarker in malignant melanoma: A systematic review and meta-analysis

báo cáo khoa học: " A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro"